GALE Related Analyst Ratings
-
Needham & Company Starts Galena Biopharma (GALE) at Buy
-
Piper Jaffray Starts Galena Biopharma (GALE) at Overweight
-
StreetInsider Rating Du Jour 11/28: Aegis Capital Sees an Easy Triple in Galena Biopharma (GALE)
-
Aegis Capital Starts Galena Biopharma (GALE) at Buy
-
Dawson James Starts Galena Biopharma (GALE) at Market Outperform
-
Cantor Fitzgerald Maintains a 'Buy' on Galena Biopharma (GALE); A Name Still Worth Exploring
-
Cantor Fitzgerald Starts Galena Biopharma (GALE) at Buy; New Approach to Breast Cancer
Back to GALE Stock Lookup
